Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02668536 · ClinicalTrials.gov registry record · Phase 1
A Sunscreen Based on Bioadhesive Nanoparticles
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT02668536 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 13 participants.
The verdict
NCT02668536, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The initial focus of the study will be on safety, sun protection factor (SPF) characterization, and substantivity (duration of protection) studies. The primary outcome of the study will be to measure the sun protection factor (SPF) of a bioadhesive nanoparticles (BNP) formulation in 20-25 healthy volunteers with fair skin.
Interventions
- DRUG Standard Sunscreen
- DEVICE BNP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2017-07-17 |
| Est. Completion | 2017-08-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02668536
The ClinicalTrials.gov registry entry for NCT02668536 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Sunscreen is the first listed.
NCT02668536 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02668536 about?
NCT02668536 is a clinical study titled "A Sunscreen Based on Bioadhesive Nanoparticles". The initial focus of the study will be on safety, sun protection factor (SPF) characterization, and substantivity (duration of protection) studies. The primary outcome of the study will be to measure the sun protection factor (SPF) of a bioadhesive nanoparticles (BNP) formulation in 20-25 healthy vo...
What is the current status of trial NCT02668536?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2017-07-17. Estimated completion is 2017-08-18.
What interventions are being tested in trial NCT02668536?
The interventions under investigation include: Standard Sunscreen (DRUG), BNP (DEVICE).
Who is sponsoring clinical trial NCT02668536?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.